4th Clinical Trials Phase I & Phase IIA Summit
Sponsors often take for granted the fact that early phase trial design and operations can make or break future studies. When hard data is severely limited and is used to predict well beyond its boundaries, the quality of that data is absolutely paramount. The data obtained from phase 1 first-in-human studies through phase 2 proof-of-concept and dose range finding studies are vital to effectively designing future registration studies. Early phase clinical trials should be safe experiments on humans, not small-scale phase 3 trials. Therefore, it is beneficial to intelligently optimize early phase clinical activity to ensure successful trial execution and regulatory approval.
The mission of the 4th Clinical Trials Phase I & Phase IIA Summit is to provide attendees with the strategies and insight necessary to ensure their early stage clinical trials are executed on time and within budget, while exploring how to leverage innovative approaches to managing clinical trials for all therapeutic areas.
Top Five Reasons to Attend
Implement adaptive study designs and predictive models to successfully accelerate early phase trials
Improve vendor identification and communication from negotiation to study execution
Overcome the evolving challenges of patient recruitment and retention for different diseases
Leverage techniques to help identify genetic predisposition and risk factors for adverse events and drug reactions
Discuss innovative strategies to optimize early phase clinical trial operations
Who Should Attend
This conference is designed for representatives from pharmaceutical, medical device and biotechnology companies with responsibilities in the following areas:
Early Phase Research/Development
Clinical Data Management/Statistics
This conference is also of interest to:
Clinical Research Organizations
Clinical/Quality Risk Consultants
Medical Informatics Companies
Functional Service Providers
Patient Engagement and Retention Services
Clinical Technology and Data Management Solution Providers
Clinical Trials of Texas, Inc.
Clinical Trials of Texas, Inc. - sponsors 4th Clinical Trials Phase I & Phase IIA Summit
Clinical Trials of Texas, Inc. (CTT) is a San Antonio-based multitherapeutic research site, founded in 2001 by President/CEO Kay Scroggins, RN, CCRC. CTT conducts approximately 120 trials a year in phases I-IV, working with more than 15 doctors in metabolic disorders, mental health, women’s health, dermatology and Alzheimer’s disease. CTT also features an inclusive 6,000 foot, 20+ bed facility for early phase services.
Covance - sponsors 4th Clinical Trials Phase I & Phase IIA Summit
Covance Inc., the drug development business of Laboratory Corporation of America Holdings (LabCorp) headquartered in Princeton, New Jersey, USA, is the world’s most comprehensive drug development company, dedicated to advancing healthcare and delivering Solutions Made Real®.
High Point Clinical Trials Center
High Point Clinical Trials Center - sponsors 4th Clinical Trials Phase I & Phase IIA Summit
High Point Clinical Trials Center has provided comprehensive (phase I-III) clinical site services since 2008. Our 42,000-square foot facility consists of three unique units for the execution of outpatient and inpatient clinical studies. In addition to healthy normal phase I studies, we focus on specialty populations such as Metabolic Diseases, Respiratory, CNS, Cardiovascular and Nicotine-related.
inSeption - sponsors 4th Clinical Trials Phase I & Phase IIA Summit
inSeption’s insistence upon securing the “right” people to integrate into a true partnership alliance with its clients eliminates the vulnerability so often felt by operational leaders faced with evaluating traditional outsourcing options. inSeption’s core competency of identifying and securing the most experienced and proficient professionals builds the crucial foundation of a successful drug development program. Actively collaborating with its clients to custom design, hand select and assemble high-performing project teams empowers inSeption to tailor its services specifically to meet the needs of their programs. The inSeption model provides increased control, full transparency of project deliverables and timelines, and significant operational and cost efficiencies.
MEDtube is an innovative video education platform for health professionals. It allows sharing videos and other materials with a community of more than 110,000 users worldwide, as well as building e-learning courses. The videoteque is updated daily and now contains almost 15,000 videos.
PharmaLeaders.com is an online environment dedicated to enriching the careers of more than 200,000 life sciences professionals. With breaking news and informative content grouped into one of nine segmented channels, in-depth special reports, job and events postings, and so much more, industry executives, manufacturers, marketers and educators can count on PharmaLeaders for the tools they need to succeed in today’s competitive market environment.
pharmaphorum drives innovation within the pharmaceutical industry, by bringing together healthcare through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.
PharmaVOICE magazine, reaches more than 41,000 qualified subscribers and 100,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharma marketing professionals to succeed in the complex and highly regulated healthcare environment. The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: planning and implementation of cutting edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the ‘360’ in our title signifies the combination of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read. By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.
Technology Networks is an internationally recognised publisher that provides access to the latest scientific news, products, research, videos and posters. Our global community is made up of over 300,000 researchers and scientific professionals from the life science, drug discover and analytical arenas.
Please contact the event manager Marilyn below for the following:
- Discounts for registering 5 or more participants.
- If you company requires a price quotation.
Event Manager Contact: marilyn.b.turner(at)nyeventslist.com
You can also contact us if you require a visa invitation letter, after ticket purchase.
We can also provide a certificate of completion for this event if required.
This Event Listing is Promoted by
New York Media Technologies LLC in association
with EXL Events Inc.
at Sheraton Philadelphia University City Hotel
3549 Chestnut Street
Philadelphia, United States